AIToday
Top Companies' AI MovesAI in HealthcareAI Stocks & MarketsAI Business & IndustryTop Companies AIPublished: Sep 3, 2026, 06:31 JST2 min read

AI healthcare stocks to watch: Pfizer, Tempus AI, Medtronic

AI healthcare stocks to watch: Pfizer, Tempus AI, Medtronic

Key takeaway

  • US-Iran oil price risks are pressuring healthcare budgets.

  • AI can help by making care more efficient.

  • Pfizer, Tempus AI, and Medtronic are highlighted as AI healthcare stocks.

3 Key Points

  1. What happened

    The article highlights three AI healthcare stocks from a screener: Pfizer (PFE), Tempus AI (TEM), and Medtronic (MDT). It notes the screen surfaced 35 more AI healthcare companies not covered in the article.

  2. Why it matters

    Higher oil prices linked to US-Iran risks are feeding inflation expectations and government bond yields, pressuring healthcare budgets and insurance costs. AI in healthcare uses data, automation, and remote monitoring to address this by doing more with less.

  3. What to watch

    Pfizer's market cap is US$162.2b, Tempus AI's is US$11.4b, and Medtronic's is US$116.0b. Each company's AI efforts come with trade-offs, including debt, losses, or execution risks noted in the article.

Ask the AI about this article →

Context & Analysis

The article frames the investment case through a macroeconomic pressure point: oil prices tied to US-Iran risks feed into higher inflation expectations and government bond yields. That dynamic puts pressure on healthcare budgets and insurance costs, making AI-driven efficiency potentially more valuable. This backdrop sets the stage for the three highlighted companies.

Pfizer is the largest by revenue and market cap, using AI to target its drug development pipeline. Tempus AI offers direct exposure through its data flywheel, where new tests and licensing deals build its datasets. Medtronic brings AI into the operating room. All three carry specific risks, such as patent expiries for Pfizer, losses for Tempus AI, and execution questions at Medtronic.

The article positions these as illustrative picks and references analyst forecasts as the source for forward-looking expectations. It emphasizes that investors should weigh the promise against the pressures and consider alternatives beyond the AI healthcare theme.

FAQ

What is Pfizer's revenue and how is it using AI?
Pfizer generates about US$62.3b in revenue and is investing in biomolecular AI foundation models through its Boltz collaboration and internal AI tools to speed drug discovery and refine clinical trials.
What is Tempus AI's business focus?
Tempus AI uses its Next AI platform and genomics-based diagnostics to turn multimodal clinical, molecular, imaging, and ECG data into decision tools for doctors and drug developers.
What AI applications does Medtronic focus on?
Medtronic's AI efforts include a surgical video and analytics platform, spine AiBLE planning tools, and an expanding robotics ecosystem aimed at improving outcomes and lowering costs.
Top Companies AIRead Original Article

Get the latest Top Companies' AI Moves news every morning

For example, today's edition would include:

  • Vertiv to Buy UtilityInnovation for $1.45BTop Companies AI · 1h ago
  • MBody AI Orchestrator Named Finalist for AI Deployment of the YearTop Companies AI · 1h ago
  • Interactive Brokers bets on AI-assisted investingTop Companies AI · 1h ago

AI-summarized, only the topics you pick — one digest a day via Email, Slack, or Discord.

Free · takes 30 seconds · unsubscribe anytimeWhat is AIToday? →

Ask AI

Ask AI anything about this article. Q&As are published on this page for other readers too.

Related Articles

Next articleOracle earnings next week to test AI trade